352 related articles for article (PubMed ID: 33581707)
1. Glycated hemoglobin variability and microvascular complications in patients with type 1 diabetes mellitus.
Er E; Ata A; Evin F; Altınok YA; Demir G; Özen S; Darcan Ş; Gökşen D
J Pediatr Endocrinol Metab; 2020 Dec; 33(12):1533-1537. PubMed ID: 33581707
[TBL] [Abstract][Full Text] [Related]
2. Association Between HbA1c Variability and Risk of Microvascular Complications in Adolescents With Type 1 Diabetes.
Virk SA; Donaghue KC; Cho YH; Benitez-Aguirre P; Hing S; Pryke A; Chan A; Craig ME
J Clin Endocrinol Metab; 2016 Sep; 101(9):3257-63. PubMed ID: 27186858
[TBL] [Abstract][Full Text] [Related]
3. [A 20-year prospective follow-up study to evaluate the development of retinopathy and nephropathy after the onset of type 1 diabetes mellitus: Contribution of glycemic control and metabolic memory].
Bolotskaya LL; Bessmertnaya EG; Shestakova MV; Shamkhalova MS; Nikankina LV; Ilyin AV; Glek IS; Zolotukhin AV; Dedov II
Ter Arkh; 2017; 89(10):17-21. PubMed ID: 29171465
[TBL] [Abstract][Full Text] [Related]
4. HbA
Baldimtsi E; Amezcua S; Ulander M; Hyllienmark L; Olausson H; Ludvigsson J; Wahlberg J
Diabetes Metab Res Rev; 2024 Jul; 40(5):e3825. PubMed ID: 38878301
[TBL] [Abstract][Full Text] [Related]
5. HbA1c variability and long-term glycemic control are linked to diabetic retinopathy and glomerular filtration rate in patients with type 1 diabetes and multiethnic background.
Rosa LCGFD; Zajdenverg L; Souto DL; Dantas JR; Pinto MVR; Salles GFDCM; Rodacki M
J Diabetes Complications; 2019 Sep; 33(9):610-615. PubMed ID: 31227288
[TBL] [Abstract][Full Text] [Related]
6. Comparative predictive ability of visit-to-visit HbA1c variability measures for microvascular disease risk in type 2 diabetes.
Yang CY; Su PF; Hung JY; Ou HT; Kuo S
Cardiovasc Diabetol; 2020 Jul; 19(1):105. PubMed ID: 32631323
[TBL] [Abstract][Full Text] [Related]
7. Long-term visit-to-visit glycemic variability as predictor of micro- and macrovascular complications in patients with type 2 diabetes: The Rio de Janeiro Type 2 Diabetes Cohort Study.
Cardoso CRL; Leite NC; Moram CBM; Salles GF
Cardiovasc Diabetol; 2018 Feb; 17(1):33. PubMed ID: 29477146
[TBL] [Abstract][Full Text] [Related]
8. Glycated albumin indicates peripheral diabetic neuropathy.
Wang N; Guo C; Han P; Li T
Acta Diabetol; 2016 Dec; 53(6):973-979. PubMed ID: 27573202
[TBL] [Abstract][Full Text] [Related]
9. A1C variability and the risk of microvascular complications in type 1 diabetes: data from the Diabetes Control and Complications Trial.
Kilpatrick ES; Rigby AS; Atkin SL
Diabetes Care; 2008 Nov; 31(11):2198-202. PubMed ID: 18650371
[TBL] [Abstract][Full Text] [Related]
10. HbA
Lind M; Pivodic A; Svensson AM; Ólafsdóttir AF; Wedel H; Ludvigsson J
BMJ; 2019 Aug; 366():l4894. PubMed ID: 31462492
[TBL] [Abstract][Full Text] [Related]
11. Glycated albumin and its variability as an indicator of cardiovascular autonomic neuropathy development in type 2 diabetic patients.
Jun JE; Lee SE; Lee YB; Ahn JY; Kim G; Jin SM; Hur KY; Lee MK; Kim JH
Cardiovasc Diabetol; 2017 Oct; 16(1):127. PubMed ID: 29017498
[TBL] [Abstract][Full Text] [Related]
12. Glycemic variability assessed by continuous glucose monitoring and the risk of diabetic retinopathy in latent autoimmune diabetes of the adult and type 2 diabetes.
Lu J; Ma X; Zhang L; Mo Y; Ying L; Lu W; Zhu W; Bao Y; Zhou J
J Diabetes Investig; 2019 May; 10(3):753-759. PubMed ID: 30306722
[TBL] [Abstract][Full Text] [Related]
13. [What glycemic control can be achieved in young diabetics without residual secretion of endogenous insulin? What is the frequency of severe hypoglycemia and subclinical complications?].
Dorchy H
Arch Pediatr; 1994 Nov; 1(11):970-81. PubMed ID: 7834046
[TBL] [Abstract][Full Text] [Related]
14. Diabetic Microvascular Complications Among Children and Adolescents in Northwestern Tanzania: A Cross-Sectional Study.
Msanga D; Reis K; Kayange N; Bakalemwa R; Kidenya B; Hau D; Mwanansao C; Mahamba D; Ottaru S; Kwiyolecha E; Peck R
Ann Glob Health; 2020 Apr; 86(1):43. PubMed ID: 32346524
[TBL] [Abstract][Full Text] [Related]
15. HbA1c levels in children with type 1 diabetes and correlation to diabetic retinopathy.
Andreasson R; Ekelund C; Landin-Olsson M; Nilsson C
J Pediatr Endocrinol Metab; 2018 Mar; 31(4):369-374. PubMed ID: 29494341
[TBL] [Abstract][Full Text] [Related]
16. Early risk stratification in pediatric type 1 diabetes.
Broe R
Acta Ophthalmol; 2015 Mar; 93 Thesis 1():1-19. PubMed ID: 25703648
[TBL] [Abstract][Full Text] [Related]
17. HbA1c variability and diabetic peripheral neuropathy in type 2 diabetic patients.
Su JB; Zhao LH; Zhang XL; Cai HL; Huang HY; Xu F; Chen T; Wang XQ
Cardiovasc Diabetol; 2018 Mar; 17(1):47. PubMed ID: 29598819
[TBL] [Abstract][Full Text] [Related]
18. Association of Glycemic Variability in Type 1 Diabetes With Progression of Microvascular Outcomes in the Diabetes Control and Complications Trial.
Lachin JM; Bebu I; Bergenstal RM; Pop-Busui R; Service FJ; Zinman B; Nathan DM;
Diabetes Care; 2017 Jun; 40(6):777-783. PubMed ID: 28404658
[TBL] [Abstract][Full Text] [Related]
19. Effects of intensive glycemic control on microvascular outcomes in type 2 diabetes mellitus are modified by long-term HbA
Wang JM; Miao MY; Jia YP; Wang XW; Wu XB; Wan ZX; Zheng Y; Qin LQ; Li FR; Chen GC
Diabetes Res Clin Pract; 2024 Feb; 208():111100. PubMed ID: 38246509
[TBL] [Abstract][Full Text] [Related]
20. Vascular endothelial growth factor (VEGF) in children, adolescents and young adults with Type 1 diabetes mellitus: relation to glycaemic control and microvascular complications.
Chiarelli F; Spagnoli A; Basciani F; Tumini S; Mezzetti A; Cipollone F; Cuccurullo F; Morgese G; Verrotti A
Diabet Med; 2000 Sep; 17(9):650-6. PubMed ID: 11051284
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
